NCT02539134View on ClinicalTrials.gov

TAK-935 Multiple Rising Dose Study in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

April 30, 2016

Study Completion Date

April 30, 2016

Conditions
Epilepsy
Interventions
DRUG

TAK-935

TAK-935 oral solution

DRUG

Placebo

TAK-935 placebo-matching oral solution

Trial Locations (1)

Unknown

Austin

Sponsors

Lead Sponsor

Takeda
All Listed Sponsors
lead

Takeda

INDUSTRY